Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FQP6Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $253,330
Award facts
- Contract value 100% obligated
- $253,329.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Ocrevus 300 mg/10 ml vials with a ceiling value of $253,329.60 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with the place of performance located at its corporate office in Conshohocken, PA 19428.
This delivery order falls under AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) that extends through December 2026. The contract vehicle functions as a comprehensive global pharmaceutical support program enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Ocrevus procurement supports the company's established role as a major vendor within DLA's medical supply chain, delivering critical pharmaceutical products across multiple therapeutic domains to meet defense and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FQP6Q?
SPE2DR26FQP6Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FQP6Q worth?
The government has obligated $253,330 on SPE2DR26FQP6Q.
Is contract SPE2DR26FQP6Q an order under another contract?
Yes. SPE2DR26FQP6Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP6Q competed?
The extent of competition for SPE2DR26FQP6Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award